We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$604M
1-Year Est. Return
96.57%
This Fund
S&P 500
This Quarter
Est. Return
+24.48%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$127M
AUM Growth
–
Cap. Flow
+$116M
Cap. Flow
% of AUM
91.23%
Top 10 Holdings %
Top 10 Hldgs %
66.8%
Holding
30
New
30
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
+$14.4M |
| 2 |
Sanofi
SNY
|
+$12.6M |
| 3 |
GSK
GSK
|
+$9.42M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$8.2M |
| 5 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$5.65M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.89% |
| 2 | Consumer Discretionary | 4.45% |
| 3 | Miscellaneous | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $21.8M | 17.15% |
+30,321
| New | +$14.4M |
2014 Q4
0 quarters
|
|
|
2
Sanofi
SNY
$93.7B
| $11.8M | 9.3% |
+259,500
| New | +$12.6M |
2014 Q4
0 quarters
|
|
|
3
GSK
GSK
$92.7B
| $8.99M | 7.06% |
+168,297
| New | +$9.42M |
2014 Q4
0 quarters
|
|
|
COV
4
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $8.74M | 6.87% |
+85,500
| New | +$8.2M |
2014 Q4
0 quarters
|
|
|
DMK
5
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $7.21M | 5.66% |
+16,694
| New | +$5.3M |
2014 Q4
0 quarters
|
|
|
PETX
6
DELISTED
Aratana Therapeutics, Inc.
PETX
| $5.8M | 4.56% |
+325,420
| New | +$4.05M |
2014 Q4
0 quarters
|
|
|
AFAM
7
DELISTED
Almost Family Inc
AFAM
| $5.67M | 4.45% |
+195,807
| New | +$5.49M |
2014 Q4
0 quarters
|
|
|
CFN
8
DELISTED
CAREFUSION CORPORATION
CFN
| $5.32M | 4.18% |
+89,600
| New | +$5.15M |
2014 Q4
0 quarters
|
|
9
Cardinal Health
CAH
$55.5B
| $5.01M | 3.94% |
+62,100
| New | +$4.9M |
2014 Q4
0 quarters
|
|
|
AGRX
10
DELISTED
Agile Therapeutics
AGRX
| $4.6M | 3.62% |
+375
| New | +$4.77M |
2014 Q4
0 quarters
|
|
|
BDSI
11
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $4.47M | 3.51% |
+372,043
| New | +$5.65M |
2014 Q4
0 quarters
|
|
12
Johnson & Johnson
JNJ
$599B
| $4.18M | 3.29% |
+40,000
| New | +$4.22M |
2014 Q4
0 quarters
|
|
|
PFNX
13
DELISTED
Pfenex Inc.
PFNX
| $4.03M | 3.16% |
+560,765
| New | +$4.25M |
2014 Q4
0 quarters
|
|
14
Option Care Health
OPCH
$4.66B
| $3.88M | 3.05% |
+138,655
| New | +$3.44M |
2014 Q4
0 quarters
|
|
15
ADMA Biologics
ADMA
$2.31B
| $2.75M | 2.16% |
+245,930
| New | +$2.81M |
2014 Q4
0 quarters
|
|
16
Orthofix Medical
OFIX
$377M
| $2.35M | 1.84% |
+78,007
| New | +$2.29M |
2014 Q4
0 quarters
|
|
|
FWP
17
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $2.27M | 1.78% |
+15,559
| New | +$2.24M |
2014 Q4
0 quarters
|
|
18
CONMED
CNMD
$1.36B
| $2.25M | 1.77% |
+50,100
| New | +$2.1M |
2014 Q4
0 quarters
|
|
19
DELISTED
Esperion Therapeutics
ESPR
| $2.17M | 1.7% |
+53,600
| New | +$1.64M |
2014 Q4
0 quarters
|
|
|
NSPH
20
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $2.11M | 1.66% |
+269,311
| New | +$2.51M |
2014 Q4
0 quarters
|
|
|
SRNE
21
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.86M | 1.46% |
+184,720
| New | +$936K |
2014 Q4
0 quarters
|
|
22
SCYNEXIS
SCYX
$39.7M
| $1.72M | 1.35% |
+2,157
| New | +$1.52M |
2014 Q4
0 quarters
|
|
23
TG Therapeutics
TGTX
$8.32B
| $1.63M | 1.28% |
+102,700
| New | +$1.34M |
2014 Q4
0 quarters
|
|
24
Merit Medical Systems
MMSI
$5.26B
| $1.61M | 1.27% |
+93,072
| New | +$1.38M |
2014 Q4
0 quarters
|
|
25
DELISTED
Cymabay Therapeutics
CBAY
| $1.2M | 0.94% |
+121,900
| New | +$980K |
2014 Q4
0 quarters
|
|
Similar funds
EFL
V
MAM
RCM
AMG
VV
VCP
EHI
Sio Capital Management's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Sio Capital Management, which disclosed 30 positions worth $127M. Its ten largest holdings account for 67% of the portfolio.
Its largest position is Quotient Limited Ordinary Shares: 30,321 shares worth $21.8M.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, followed by Consumer Discretionary and Miscellaneous.
- Sio Capital Management's largest Q4 2014 buy was Quotient Limited Ordinary Shares: 30,321 shares worth $21.8M.
- Sio Capital Management's ten largest holdings make up 67% of its $127M portfolio in Q4 2014.
- Sio Capital Management disclosed 30 positions in Q4 2014, its first 13F filing on record.
Based on Sio Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.